Economic evaluation of the management of pain in osteoarthritis

Drugs

Volumn 52, Issue SUPPL. 3, 1996, Pages 48-58

  Tugwell, Peter ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COST BENEFIT ANALYSIS; DRUG COST; HEALTH ECONOMICS; HUMAN; OSTEOARTHRITIS; PAIN; PHARMACOECONOMICS; REVIEW; SIDE EFFECT;

EID: 0029912040     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199600523-00008     Document Type: Review

References (14)

1. Klashman DJ, Moreland LW, Ike RW, et al. Occult presence of CPPD crystals in patients undergoing arthroscopic knee irrigation for refractory pain related to osteoarthritis. Arthritis Rheum 1994; 37 Suppl.: S240
2. Fisher NM, Greshani GE, Pendergast DR. Effects of a quantitative progressive rehabilitation program applied unilaterally to the osteoarthritic knee. Arch Phys Med Rehabil 1993; 74: 1319-26
3. Fisher NM, Gresham GE, Abrams M, et al. Quantitative effects of physical therapy on muscular performance in subjects with osteoarthritis of the knees. Arch Phys Med Rehabil 1993; 74: 840-7
4. Jan MH, Lai JS. The effects of physiotherapy on osteoarthritis knees of females. J Formos Med Assoc 1993; 90: 1008-13
5. Martin L, Edworthy SM, Nutting A, et al. Exercise in the treatment of osteoarthritis of the knee. Arthritis Rheum 1995; 38 Suppl.: S241
6. Slemenda C, Brizendine E, Katz B, et al. Strength and osteoarthritis: a community study. Arthritis Rheum 1995; 38 Suppl.: S382
7. Fordyce WE, Fowler RS, Lehmann JR, et al. Operant conditioning in the treatment of chronic pain. Arch Phys Med Rehabil 1973; 54: 399-408
8. Keefe FJ, Caldwell DS, Queen KT, et al. Osteoarthritic knee pain: a behavioral analysis. Pain 1987; 28: 309-21
9. Caudill M, Schnable R, Zuttermeister P, et al. Decreased clinic use by chronic pain patients: response to behavioral medicine intervention. Clin J Pain 1991; 7: 305-310
10. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36: 439-46
11. ®) in the treatment of osteoarthritis of the knee: a Canadian multicentre trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis and Cartilage 1995; 3: 213-26
12. March L, Irwig L, Schwarz J, et al. n of 1 trials comparing a non-steroidal inflammatory drug with paracetamol in osteoarthritis. BMJ 1994; 309: 1041-5
13. Scholes D, Stergachis A, Penna PM, et al. Nonsteroidal anti-inflammatory drug discontinuation in patients with osteoarthritis. J Rheumatol 1995; 22: 708-12
14. Proceedings of the second OMERACT Conference. J Rheumatology 1995; 22: 980-1433